View Cart  

Another Possible Blockbuster Drug for Gilead Approved by FDA

Zydelig is indicated for use in combination with Genentech’s Rituxan to treat patients whose chronic lymphotic leukemia has returned. Read More

AstraZeneca, Roche Team Up to Create Lung Cancer Diagnostic

The test will be a companion to AstraZeneca’s investigational compound, AZD9291. Read More
The Solutions Center